Abstract:Because major cardiovascular disease states are characterized by defects in adenylyl cyclase regulation, it becomes important to understand the mechanisms by which adenylyl cyclase activators affect inotropy and chronotropy in intact conscious animals. Accordingly, we examined the inotropic and chronotropic responses to forskolin in 11 normal conscious, chronically instrumented dogs and 3 dogs with ventricular denervation (VD). Left ventricular first derivative of pressure (LV dP/dt) increased by 96 +/- 7%, P < 0.05, in response to forskolin (50 nmol.kg-1.min-1) in normal dogs and by significantly less, 52 +/- 14%, in VD dogs. Circulating norepinephrine (NE) levels increased similarly in both groups (from 226 +/- 18 to 389 +/- 33 pg/ml in normal dogs, from 177 +/- 23 to 329 +/- 71 pg/ml in VD dogs). In the presence of ganglionic blockade, the increase in LV dP/dt in response to forskolin was reduced (+62 +/- 4%) in normal dogs but was unchanged in VD dogs (+52 +/- 12%). Ganglionic blockade abolished the increase in circulating NE levels in both groups. Increases in heart rate in the presence of ganglionic blockade (+54 +/- 6 beats/min) were less than in the presence of atropine alone (+92 +/- 10 beats/min). Notably, the LV dP/dt and heart rate responses to forskolin were further attenuated by beta-adrenergic receptor blockade in the presence and absence of ganglionic blockade. Morphine also attenuated the increases in both LV dP/dt and plasma NE in response to forskolin. Increases in LV dP/dt in response to NKH-477 (30 micrograms/kg), a water-soluble forskolin derivative, were similar before and after ganglionic blockade (+63 +/- 8 and +51 +/- 10%, respectively). However, in vitro experiments in LV sarcolemmal membrane preparations demonstrated that stimulation of adenylyl cyclase by forskolin and NKH-477 was not affected by beta-adrenergic receptor blockade. These results indicate that in conscious dogs, inotropic and chronotropic effects of forskolin are not only due to direct activation of adenylyl cyclase, but the effects also are mediated by neural mechanisms and potentiated by the prevailing level of sympathetic tone.

The Therapeutic Potential of the Labdane Diterpenoid Forskolin

Biotechnological interventions for the production of forskolin, an active compound from the medicinal plant, Coleus forskohlii

Progress in heterologous biosynthesis of forskolin

[Recent advances in biosynthesis of forskolin]

A Novel Approach to Defeat Obesity: An in vitro and in vivo Evaluation of the Active Diterpene in Coleus forskohlii (ForcslimTM)

The Natural cAMP Elevating Compound Forskolin in Cancer Therapy: Is It Time?

Forskolin is an effective therapeutic small molecule for the treatment of hypertrophic cardiomyopathy through ADCY6/cAMP/PKA pathway

[Studies on the Chemical Constituents of Coleus Forskohlii].

Matrix Solid-Phase Dispersion Extraction for Chromatographic Analysis of Labdane Diterpenoids in Coleus Forskohlii

Discovery of a novel series of α-terpineol derivatives as promising anti-asthmatic agents: Their design, synthesis, and biological evaluation.

Stachydrine, a pyrrole alkaloid with promising therapeutic potential against metabolic syndrome and associated organ dysfunction

Kinetic Study of the Degradation of Forskolin in Aqueous Systems by Stability-Indicating Hplc Method and Identification of Its Degradation Products

Skeletal Transformations of Terpenoid Forskolin Employing an Oxidative Rearrangement Strategy

Local Administration of Lipid‐Silica Nanohybrid‐Carried Forskolin Modulates Thermogenesis in Human Adipocytes and Impedes Weight Gain in Mice

Anti-Inflammatory Activity of Labdane and Norlabdane Diterpenoids from Leonurus sibiricus Related to Modulation of MAPKs Signaling Pathway

The Labdane Ent-3-Acetoxy-Labda-8(17), 13-Dien-15-Oic Decreases Blood Pressure In Hypertensive Rats

Neurally Mediated Cardiac Effects of Forskolin in Conscious Dogs.

Exploring the pharmacological potential of Lepionurus sylvestris blume: from folklore medicinal usage to modern drug development strategies using in vitro and in silico analyses

Fritillaria steroidal alkaloids and their multi-target therapeutic mechanisms: insights from network pharmacology

Tissue-Level Effect of Andrographis and Ashwagandha Metabolites on Metabolic and Inflammatory Gene Expression in Skeletal Muscle and Adipose Tissue: An Ex Vivo/In Vitro Investigation

A Convergent Approach to the Forskolin Skeleton